Year: 2024 | Month: October | Volume: 11 | Issue: 10 | Pages: 606-609
DOI: https://doi.org/10.52403/ijrr.20241056
A Case Report on Multi Drug Resistance in Community Acquired Pneumonia Due to Escherichia Coli with Cholangiocarcinoma
Dhanush R1, Puneeth Hosmani2
1,2Department of Pharmacy Practice, Bapuji Pharmacy College, Davangere, Karnataka, India./p>
Corresponding Author: Dhanush R
ABSTRACT
Escherichia coli is an important cause of severe community acquired pneumonia with mortality higher than pneumococcal pneumonia but like other gram-negative pneumonia. Antibiotics are the treatment of choice in treating pneumonia. When it comes to bacterial community-acquired pneumonia, multidrug resistant Escherichia coli (MDR E. Coli) is a less common cause than Staphylococcus aureus and Streptococcus pneumoniae. The majority of patients with community-acquired pneumonia (CAP) respond well to typical antibiotic regimens consisting of either a fluoroquinolone or a macrolide plus cephalosporin. We present a case where patient diagnosed with E. coli causing pneumonia showed MDR to various empirical antibiotics and managed with culture sensitive antibiotics. Antibiotic resistance has become a major issue for healthcare providers, where the effective management of patients will be more challenging which necessitates the need for optimising the use of antibiotics.
Keywords: Multi Drug Resistance, Community Acquired Pneumonia, Escherichia Coli, Cholangiocarcinoma.
[PDF Full Text]